Ethylestrenol
Generic Name: ethylestrenol
Manufactured by ORGANON USA INC. Dosage form: TABLET. Route: ORAL. Active ingredients: ETHYLESTRENOL (2MG). Application: NDA014005.
Overview
Manufactured by ORGANON USA INC. Dosage form: TABLET. Route: ORAL. Active ingredients: ETHYLESTRENOL (2MG). Application: NDA014005.
Dosage
Available as tablet for oral use.
Related Medications
Levothyroxine, Liothyronine
levothyroxine, liothyronine
l-Triiodothyronine [EPC]
NP Thyroid ® (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil. Contains no ingredient made from a gluten-containing grain (wheat, barley, rye).
Apraclonidine
apraclonidine
DESCRIPTION Apraclonidine ophthalmic solution 0.5% contains apraclonidine hydrochloride, an alpha adrenergic agonist, in a sterile isotonic solution for topical application to the eye. Apraclonidine hydrochloride is a white to off-white powder and is highly soluble in water. Its chemical name is 2-[(4-amino-2,6 dichlorophenyl) imino]imidazolidine monohydrochloride with an empirical formula of C 9 H 11 Cl 3 N 4 and a molecular weight of 281.57 g/mol.
Aflibercept-mrbb
aflibercept-mrbb
11 DESCRIPTION Aflibercept-mrbb is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept-mrbb is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.